Related Experiment Video
Updated: Jul 14, 2026

10:26
Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Mitochondrial-derived ROS in edelfosine-induced apoptosis in yeasts and tumor cells
Hui Zhang1, Consuelo Gajate, Li-Ping Yu
1Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China.
Acta Pharmacologica Sinica
|May 18, 2007
Summary
Edelfosine induces apoptosis in yeast and human tumor cells by generating reactive oxygen species (ROS) from mitochondria. This suggests yeast can model edelfosine
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3, edelfosine) is an alkylphosphocholine with demonstrated antitumor activity.
- The precise mechanisms underlying edelfosine's cytotoxicity, particularly its role in inducing apoptosis, require further elucidation.
Purpose of the Study:
- To investigate if the cytotoxic mechanism of edelfosine in human tumor cells is conserved in yeast.
- To explore the role of reactive oxygen species (ROS) and mitochondrial function in edelfosine-induced apoptosis.
Main Methods:
- Assessed ROS generation using a modified nitro blue tetrazolium assay.
- Detected apoptotic yeast cells via terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay.
- Utilized cytofluorimetric analysis for DNA fragmentation and ROS measurement in Jurkat cells.
Main Results:
- Edelfosine induced apoptosis and ROS generation in Saccharomyces cerevisiae, inhibited by rotenone and alpha-tocopherol.
- Edelfosine increased ROS in human leukemic cells prior to apoptosis; Bcl-2 overexpression abrogated these effects.
- Mitochondrial membrane potential changes were observed in both yeast and Jurkat cells.
Conclusions:
- Edelfosine induces apoptosis in yeast and human tumor cells through a mitochondrion-dependent pathway involving ROS.
- Yeast serves as a viable model for studying the antitumor mechanisms of edelfosine.
